Amalgamated Bank’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-496
Closed -$6K 2461
2025
Q4
$6K Sell
496
-96
-16% -$1.57K ﹤0.01% 2660
2025
Q3
$12K Hold
592
﹤0.01% 2386
2025
Q2
$8K Hold
592
﹤0.01% 2541
2025
Q1
$5K Hold
592
﹤0.01% 2681
2024
Q4
$3K Hold
592
﹤0.01% 2863
2024
Q3
$5K Hold
592
﹤0.01% 2769
2024
Q2
$6K Hold
592
﹤0.01% 2704
2024
Q1
$7K Sell
592
-1,795
-75% -$26K ﹤0.01% 2601
2023
Q4
$34K Sell
2,387
-176
-7% -$1.69K ﹤0.01% 2406
2023
Q3
$20K Hold
2,563
﹤0.01% 2662
2023
Q2
$37K Buy
2,563
+216
+9% +$3.08K ﹤0.01% 2446
2023
Q1
$34K Sell
2,347
-5,267
-69% -$88.1K ﹤0.01% 2461
2022
Q4
$128K Sell
7,614
-1,057
-12% -$18.3K ﹤0.01% 2036
2022
Q3
$129K Buy
8,671
+42
+0.5% +$830 ﹤0.01% 2033
2022
Q2
$236K Buy
8,629
+60
+0.7% +$1.78K ﹤0.01% 1799
2022
Q1
$323K Sell
8,569
-383
-4% -$17K ﹤0.01% 1739
2021
Q4
$556K Buy
8,952
+5,890
+192% +$446K ﹤0.01% 1527
2021
Q3
$262K Buy
+3,062
New +$192K ﹤0.01% 1893

Other funds holding OPRX

Amalgamated Bank's OPRX Position: Q1 2026 in Review

Amalgamated Bank sold out of OptimizeRx (OPRX) in Q1 2026, closing a stake of 496 shares — an estimated $6K sold.

Amalgamated Bank first reported a position in OPRX in Q3 2021 and held it in 18 quarters. The position peaked at $556K in Q4 2021. 127 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.

  • Amalgamated Bank reported no remaining OptimizeRx position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 496 OptimizeRx shares in Q1 2026, an estimated $6K.
  • Amalgamated Bank first reported a position in OptimizeRx in Q3 2021 and held it in 18 quarters.
  • Amalgamated Bank's OptimizeRx position peaked at $556K in Q4 2021.
  • 127 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.